Literature DB >> 18341715

Prognostic relevance of the histological subtype of renal cell carcinoma.

Marcos F Dall'Oglio1, Alberto A Antunes, Antonio C Pompeo, Alcides Mosconi, Katia R M Leite, Miguel Srougi.   

Abstract

OBJECTIVE: According to several studies, when the histological subtype of renal cell carcinoma is established it is possible to attribute a different life expectancy to each patient. We analyzed the prognostic significance of the histological subtype in renal cell carcinoma.
MATERIALS AND METHODS: The authors retrospectively analyzed the follow-up of 230 patients after radical or conservative renal surgery. The histological characteristics of the different subtypes of tumor were obtained and the disease-free and cancer-specific survival curves for the clear cell, cromophobic, papillary, collecting duct (Bellini) subtypes and those with sarcomatoid differentiation were individualized.
RESULTS: The disease-free and cancer-specific survival rates for clear cell tumors were 76.6% and 68.0% respectively, 71.2% and 82.1% respectively for the cromophobic type, 71.1% and 79.8% respectively for the papillary type, 26.9% and 39.3% respectively for the sarcomatoid type, and 0.0% and 0.0% respectively for the collecting ducts (p < 0.001).
CONCLUSION: The histological subtypes of renal tumors can stratify patients into different prognostic groups only when the sarcomatoid differentiation is present.

Entities:  

Mesh:

Year:  2008        PMID: 18341715     DOI: 10.1590/s1677-55382008000100002

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  6 in total

1.  Histopathology of surgically treated renal tumours in young adults: a developing country perspective.

Authors:  Muhammed Mubarak; Javed I Kazi; Rehan Mohsin; Altaf Hashmi; Syed Ali Anwer Naqvi; Syed Adeeb Ul Hassan Rizvi
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-16       Impact factor: 4.553

2.  Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage.

Authors:  Kirk A Keegan; Clayton W Schupp; Karim Chamie; Nicholas J Hellenthal; Christopher P Evans; Theresa M Koppie
Journal:  J Urol       Date:  2012-06-13       Impact factor: 7.450

Review 3.  The Potential Role of Lysosomal Sequestration in Sunitinib Resistance of Renal Cell Cancer.

Authors:  Kaamar Azijli; Kristy J Gotink; Henk M W Verheul
Journal:  J Kidney Cancer VHL       Date:  2015-01-21

4.  Comparative analysis of histopathological subtypes of renal cell carcinoma in the Middle East compared to other world regions.

Authors:  Mark Khauli; Nassib Abou Heidar; Jad A Degheili; Nizar Hakam; Mouhamad Al-Moussawy; Mohammed Shahait; Jose El-Asmar; Gerges Bustros; Ali Merhe; Rami Nasr; Muhammad Bulbul; Wassim Wazzan; Albert El-Hajj; Ali Shamseddine; Hala Kfoury; Deborah Mukherji; Raja Khauli
Journal:  Urol Ann       Date:  2021-03-04

5.  MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma.

Authors:  Eman A Toraih; Afaf T Ibrahiem; Manal S Fawzy; Mohammad H Hussein; Saeed Awad M Al-Qahtani; Aly A M Shaalan
Journal:  Oxid Med Cell Longev       Date:  2017-09-20       Impact factor: 6.543

6.  Frequency, incidence and survival outcomes of clear cell renal cell carcinoma in the United States from 1973 to 2014: A SEER-based analysis.

Authors:  Xiao Feng; Lina Zhang; Wenzhi Tu; Shundong Cang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.